Results 301 to 310 of about 24,047,971 (353)
Some of the next articles are maybe not open access.
Nature Reviews Cancer, 2018
The recent advances in in vitro 3D culture technologies, such as organoids, have opened new avenues for the development of novel, more physiological human cancer models. Such preclinical models are essential for more efficient translation of basic cancer research into novel treatment regimens for patients with cancer.
Jarno Drost, Hans Clevers
openaire +4 more sources
The recent advances in in vitro 3D culture technologies, such as organoids, have opened new avenues for the development of novel, more physiological human cancer models. Such preclinical models are essential for more efficient translation of basic cancer research into novel treatment regimens for patients with cancer.
Jarno Drost, Hans Clevers
openaire +4 more sources
This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer.
Hyuna Sung+2 more
exaly +2 more sources
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across ...
Frank Bray+2 more
exaly +2 more sources
This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC).
Frank Bray, Hyuna Sung, Rebecca L Siegel
exaly +2 more sources
International Journal of Gynecological Cancer, 2002
With the human genome sequence now determined, the field of molecular medicine is moving beyond genomics to proteomics. In the field of cancer research, the key question is: how can oncologists best use techniques of proteomics in basic research and clinical application?
John J. Kavanagh, Wei Hu, W. Wu
openaire +3 more sources
With the human genome sequence now determined, the field of molecular medicine is moving beyond genomics to proteomics. In the field of cancer research, the key question is: how can oncologists best use techniques of proteomics in basic research and clinical application?
John J. Kavanagh, Wei Hu, W. Wu
openaire +3 more sources
The Imperial Cancer Research Fund—Cancer research for the future [PDF]
Paul Nurse, winner of the 1998 Albert Lasker Basic Medical Research Award for his work on the cell cycle, began working at the Imperial Cancer Research Fund (ICRF) as Head of the Cell Cycle Control laboratory in 1984. Twelve years later he was appointed Director General of the ICRF and now describes the origins, structure and goal of the UK's largest ...
openaire +2 more sources
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology
Nature Cancer, 2022Artem Shmatko+3 more
semanticscholar +1 more source
Journal of Cancer Research and Clinical Oncology
Forum, 2021F. Lordick, K. Höffken
semanticscholar +1 more source
THE MEANING OF CANCER RESEARCH
Journal of the American Medical Association, 1948While the human body is a beautifully organized, well governed society of cells, probably no living species is a victim of more disorders and maladjustments than man. From study of the behavior of the various disorders much has been learned about the orderly, normal behavior of living units, i. e., cells, organs and systems.
openaire +3 more sources